Patents by Inventor Michael FASSLER

Michael FASSLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES FOR THE TREATMENT OF SYNUCLEINOPATHIES AND NEUROINFLAMMATION
    Publication number: 20230340091
    Abstract: Anti-alpha-synuclein antibodies and antigen-binding fragments thereof (e.g., scFvs) are provided.
    Type: Application
    Filed: November 10, 2022
    Publication date: October 26, 2023
    Inventors: Michael FASSLER, Jacob GEORGE
  • Antibodies for the treatment of synucleinopathies and neuroinflammation
    Patent number: 11512125
    Abstract: Anti-alpha-synuclein antibodies and antigen-binding fragments thereof (e.g., scFvs) are provided. Also provided are methods of using the same in therapy.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: November 29, 2022
    Inventors: Michael Fassler, Jacob George
  • TREM2 ANTIBODIES AND USES THEREOF
    Publication number: 20220127356
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). The anti-TREM2 antibodies or antigen-binding fragments thereof are useful, for example, in detecting TREM2 and in treating neurodegenerative diseases.
    Type: Application
    Filed: December 10, 2019
    Publication date: April 28, 2022
    Inventors: Michael FASSLER, Jacob GEORGE
  • TRANSTHYRETIN ANTIBODIES AND USES THEREOF
    Publication number: 20210230257
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to human transthyretin (TTR). The anti-TTR antibodies or antigen-binding fragments thereof are useful, for example, in detecting TTR and in treating TTR amyloidosis in a subject.
    Type: Application
    Filed: June 26, 2019
    Publication date: July 29, 2021
    Inventors: Michael FASSLER, Jacob GEORGE
  • ANTIBODIES FOR THE TREATMENT OF SYNUCLEINOPATHIES AND NEUROINFLAMMATION
    Publication number: 20210214429
    Abstract: Anti-alpha-synuclein antibodies and antigen-binding fragments thereof (e.g., scFvs) are provided. Also provided are methods of using the same in therapy.
    Type: Application
    Filed: June 27, 2019
    Publication date: July 15, 2021
    Inventors: Michael FASSLER, Jacob GEORGE